Skip to main content

Mechanisms Underlying Endocrine Disruption and Breast Cancer

  • Chapter
Endocrine Disrupters

Part of the book series: Environmental Science and Technology Library ((ENST,volume 18))

Summary

This article reviews the effects of Endocrine Disrupters (EDs) on cancer incidence in humans, the analysis being practically restricted to the influence of xenoestrogens on the occurrence of breast cancer. Although receptor-mediated mechanisms play an important role in eliciting the effects of (xeno)oestrogens (XEs), it should not be overlooked that other pathways exist, and that any evaluation must therefore consist of the net result of all influences. It is not acceptable to base the evaluation of the effects of xenoestrogens, or their inclusion in the category of EDs, solely on their property to bind the oestrogen receptor (ER). Other mechanisms contribute in eliciting the oestrogenic response and are briefly reviewed. They include serum factors; the binding to carrier proteins; alterations in metabolic pathways; interactions between oestrogens; growth factors and their receptors and oncogenes; disturbances in signal transduction pathways and interference with several accessory mechanisms of carcinogenesis. The particular carcinogenesis mechanisms underlying the action of (xeno)oestrogens are discussed. This mechanism implicates the absence of any threshold and-consequently-inducing effects at the lowest possible concentrations: one molecule. Other factors influencing the effects of XEs are represented by the occurrence of a membrane oestrogen receptor, different from the traditional nuclear ER, participating in the regulation of Prolactin production by the hypophysis after stimulation of the hypothalamic-hypophyseal pathways. Strong co-operation also exists with thyroid hormones. Many epidemiological studies, of which some are critically reviewed, support the basic role of XEs as one of the causative factors of breast cancer. This only serves to underscore the compulsory application of the precautionary principle, once a compound has been proven to exert endocrine disrupting properties, and the necessity to evaluate all modes of action of EDs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Advis, J.P., Oliver, L.M., Jacobs, D., Richards, J.S., and Ojeda, S.R. (1981) Hyperprolactinemia-induced precocious puberty: studies on the mechanism(s) by which prolactin enhances ovarian progesterone responses to gonadotropins in pubertal rats, Endocrinology 108, 1333–1342.

    Article  PubMed  CAS  Google Scholar 

  • Amaral Mendes, J.J., and Pluygers, E. (1999) Use of biochemical and molecular biomarkers for cancer risk assessment in humans, in V.J. Cogliano, E.G. Luebeck, and G.A. Zapponi (eds), Perspectives on Biologically Based Cancer Risk Assessment, NATO series on challenges of modern society, volume 23, Kluwer Academic/Plenum Publishers, New York, pp. 81–182.

    Google Scholar 

  • Ambrosone, C.B., Freudenheim, J.L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, J.R., Laughin, R., Nemoto, T., Michalek, A.M., Harrinton, A., Ford, T.D., and Shields, P.G. (1995) Cytochrome P450 lAl and glutathione S-transferase (M1) genetic polymorphisms and post-menopausal breast cancer risks, Cancer Research 55, 34833485.

    Google Scholar 

  • Andersen, H.R., Andersson, A.M., Arnold, S.F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P. Christiansen, L.B., Gissel, B., Hummel, R., Bonefeld Jorgensen, E., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J.??Moller, A., Nielsen, J.B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K.L., Perez, P., Skakkebaek, N.E., Sonnenschein, C., Soto, A.M., Sumpter, J.P., Thorpe, S.M., and Grandjean, P. (1999) Comparison of short-term oestrogenicity tests for identification on hormone-disrupting chemicals, Environ. Health Perspect. 107 Suppl. 1?? 89–108.

    Google Scholar 

  • Ashby, J.?? Houthoff, E., Kennedy, S.J., Stevens, J.?? Bars, R., Jekat, F.W., Campbell, P., Van Miller, J., Carpanini, F.M., and Randall, G.L.B. (1997) The challenge posed by endocrine-disrupting chemicals, Environ. Health Perspect. 105?? 104–169.

    Google Scholar 

  • Bernstein, L., Yuan, J., Ross, R.K. (1990) Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies, Cancer Causes Control 1, 51–58.

    Google Scholar 

  • Bertazzi, P.A., Pesatori, A.C., Consonni, D., Tironi, A., Landi, M.T., and Zocchetti, C. (1993) Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin, Epidemiology 4, 398–406.

    Article  PubMed  CAS  Google Scholar 

  • Bhattacharya, A., and Vonderhaar, B.K. (1979) Thyroid hormone regulation of prolactin binding in mouse mammary glands Biochem, Biophys. Res. Commun. 88, 14051411.

    Google Scholar 

  • Bradlow, H.L., Davis, D.L., Lin, G., Sepkovic, D.?? and Tiwari, R. (1995) Effects of pesticides on the ratio of 16 cd2-Hydroxyoestrone: a biologic marker of breast cancer risk, Environ. Health Perspect. 103 Suppl. 7?? 147–150.

    Google Scholar 

  • Branham, W.S., Dial, S., Baker, M.E., Moland, C., and Shaehan, D.M. (2000) Assessment of xenoestrogen binding to rat and human serum oestrogen binding proteins, poster presentation, in A.M. A.dersson, K.M Grigor, and N.E. Skakkebaek (eds), Abstract Book, RH Workshop on Hormones and Endocrine Disrupters in Food and Water: Possible Impact on Human Health, Copenhagen, 27–30 May 2000, pp. 81–82 (proceedings to become available electronically).

    Google Scholar 

  • Breast Cancer Prevention Collaborative Research Group (Founding members: Davis, D.L., Hoel, D.G., Morrison, H., Richter, E., Santos-Burgos, C., Westin, J., and Wolff, M. (1992) Breast cancer: environmental factors, Lancet 340, 904.

    Google Scholar 

  • Breuer, B., Luo, J.C., De Vivo, I., Pineus, M., Tatum, A.H., Daucher, J., Minick, R., Osborne, M., Miller, D., Nowak, E., Cody, H., Carney, W.P., and Brandt-Rauf, P.W. (1993) Detection of elevated C-erbB-2 oncopeptide in the serum and tissue in breast cancer, Med. Sci. Res. 21, 383–384.

    Google Scholar 

  • Bruning, P.F., Bonfrer, J.M.C., and Hart, A.A.M. (1985) Non-protein bound oestradiol, sex-hormone-binding globulin, breast cancer and breast cancer risk, Brit. J. Cancer 51, 479–484.

    Article  PubMed  CAS  Google Scholar 

  • Bulbrook, R.D., Wang, D.Y., Hayward, J.L., Kwa, H.G., and Cleton, F. (1981) Plasma prolactin levels in a female population: relation to breast cancer, Int. Jl. Cancer 28, 4345.

    Google Scholar 

  • Charlier, C., Meurisse, M., Herman, Ph., Gaspard, U., and Plomteux, G. (2000) Organochlorine compounds in relation to breast cancer, poster presentation, in A.M. A.dersson, K.M Grigor, and N.E. Skakkebaek (eds), Abstract Book, RH Workshop on Hormones and Endocrine Disrupters in Food and Water: Possible Impact on Human Health, Copenhagen, 27–30 May 2000, pp. 64–65 (proceedings to become available electronically).

    Google Scholar 

  • Cheek, A.O., Vonier, P.M., Oberdörster, E., Collins Burow, B., and McLachlan, J.M. (1998) Environmental signalling: Biological context for endocrine disruption, Environ. Health Perspect. 106 Suppl. 1?? 5–10.

    Google Scholar 

  • Cohen, S.M., and Ellwein, L.B. (1990) Cell proliferation in carcinogenesis, Science 249, 1007–1011.

    Article  PubMed  CAS  Google Scholar 

  • Colborn, T., and Clement, C. (eds) (1992) Chemically Induced Alterations in Sexual and Functional Development: the Wildlife/Human Connection, Princeton Scientific Publishing, Princeton, N.J., 403 pp.

    Google Scholar 

  • Connor, K., Howell, J., Chen, I., Lin, H., Berhane, K., Sciarretta, C., Safe, S., and Zacharewski, T. (1996) Failure of chloro-s-triazine-derived compounds to induce oestrogen receptor-mediated responses in vivo and in vitro, Fundam. Appl. Toxicol. 30, 93–101.

    Google Scholar 

  • Cooper, R.L., Stoker, T.E., Goldman, J.M., Hein, J., and Tyrey, L. (1996). Atrazine disrupts hypothalamic control of pituitary-ovarian function (abstract), Toxicologist 30, 66.

    Google Scholar 

  • Crisp, T.M., Clegg, E.D., Cooper, R.L., Wood, W.P., Anderson, D.G., Baetcke, K.P., Hoffmann, J.L., Morrow, M.S., Rodier, D.J., Schaeffer, J.E., Tonart, L.W., Zeeman, M.G., and Patel, Y.M. (1998) Environmental endocrine disruption: an effects assessment and analysis, Environ. Health Perspect. 106 Suppl. 1?? 11–56.

    Google Scholar 

  • Davis, D.L., Bradlow, H.L., Wolff, M., Woodruff, T., Hoel, D.G., and Anton-Culver, H. (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer, Environ. Health Perspect. 101, 372–377.

    Article  PubMed  CAS  Google Scholar 

  • Dees, C., Foster, J.S., Ahmend, S., and Wimallasena, J. (1997a) Dietary oestrogens stimulate human breast cells to enter the cell cycle?? Environ. Health Perspect. 105 Suppl. 3, 633–636.

    Google Scholar 

  • Dees, C., Askari, M., Garrett, S., Gehrs, K., Henely, D., Ardies, C.M., and Travis, C. (1997b) Oestrogenic and DNA-damaging activity of Red n°3 in human breast cancer cells?? Environ. Health Perspect. 105 Suppl. 3, 625–632.

    Google Scholar 

  • Dewailly, E., Dodin, S., Verreault, R., Ayotte, P., Sauve, L., and Morin, J. (1994) High organochlorine body burden in women with oestrogen receptor positive breast cancer, Jl. Natl. Cancer Inst. 86, 232–234.

    Article  CAS  Google Scholar 

  • Dowdeswell, E. (1997) Endocrine disrupting chemicals, Address, as Executive Director of the United Nations Environment Programme, at the Global International 12` h General Assembly, European Parliament, Brussels, 7 May 1997.

    Google Scholar 

  • Falck, F.Y., Ricci, A., Jr., Wolff, M.S., Godbold, J., and Deckers, J. (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer?? Arch. Envir. Health 47, 143–146.

    Google Scholar 

  • Fishman, J., and Martucci, C. (1980) Biological properties of 16 a-hydroxyoestrone: implications in oestrogen physiology and pathophysiology, Jl. Clin. Endocrinol. and Metab. 51, 611–615.

    Google Scholar 

  • Flesch-Janys?? D., Berger?? J., Manz, A., Nagel, S., and 011roge?? I. (1993) Exposure to polychlorinated dibenzo-p-dioxins and furans and breast cancer mortality in a cohort of female workers of a herbicide producing plant in Hamburg, Germany?? Proceedings of the 1993 Dioxin Conference? Vienna, 9 September 1993, pp. 381–384.

    Google Scholar 

  • Ghanaati, Z., Peters, H., Müller, S., Ventz, M., Pfüller, B., Enchshargal, Z.A., Rohde, W., and Dörner, G. (1999) Endocrinological and genetic studies in patients with polycystic ovary syndrome (PCOS)?? Neuroendocrinology Letters 20, 323–327.

    Google Scholar 

  • Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek?? J., Dickson, C., Barnes, D., and Peters, G. (1994) Amplification and over-expression of Cyclin D1 in breast cancer detected by immunohistochemical staining?? Cancer Research 54, 1812–1817.

    Google Scholar 

  • Gjorgov, A.N. (1993) Emerging world-wide trends of breast cancer incidence in the 1970s and 1980s: data from 23 cancer registration centres, Europ. Jl. Cancer Prey. 2, 423440.

    Google Scholar 

  • Guernsey, D.L., and Fisher, P.B. (1990) Thyroid hormone and neoplastic transformation, Crit. Rev. Oncog. 1, 389–408.

    PubMed  CAS  Google Scholar 

  • Herbst, A.L., Ulfelder, H., and Poskanzer, D.C. (1971) Adenocarcinoma of the vagina. Association of maternal diethylstilboestrol therapy with tumour appearance in young women, N. Engl. J. Med. 284, 878–881.

    Google Scholar 

  • Howard, C.V. (1997) Synergistic effects of chemical mixtures. Can we rely on traditional toxicology? The Ecologist 27, 192–195.

    Google Scholar 

  • Hoyer, A.P., Grandjean, P., Jorgensen, T., Brock, J.W., and Hartvig, A. (1998) Organochlorine exposure and risk of breast cancer, Lancet 352, 1816–1820.

    Google Scholar 

  • Huff, J. (1993) Issues and controversies surrounding qualitative strategies for identifying and forecasting cancer causing agents in the human environment, Pharmacol. and Toxicol. 72 Suppl., S12–S25.

    Google Scholar 

  • Huggins, C., and Hodges, C.V. (1941) Studies on prostatic cancer: the effect of castration, oestrogen and androgen injections on serum phosphatase, Cancer Research 1, 293297.

    Google Scholar 

  • IARC - International Agency for Research on Cancer (1992) Mechanisms of carcinogenesis in risk identification, in H. Vainio, P.N. Magee, D.B. McGregor, and A.J. McMichael (eds) Scientific Publications n° 116, Lyon, 615 pp.

    Google Scholar 

  • Ignar-Trowbridge, D.N., Pimentel, M., Teng, C.T., Korach, K.S., and McLachlan, J.A. (1995) Cross-talk between Peptide Growth Factors and Oestrogen Receptor signalling systems, Environ. Health Perspect. 103 Suppl. 7?? 35–38.

    Google Scholar 

  • ISE - International School of Ethology (1996) Report on the 11`h workshop held in Erice (Sicily), on Environmental Endocrine Disrupting Chemicals: Neural, Endocrine and Behavioural Effects, Proposed by the MCR Institute for Environment and Health for the Workshop on Endocrine Disrupters held in Weybridge, 2–4 December 1996.

    Google Scholar 

  • Jones, L.A., Ota, D.M., Jackson, G.A., Jackson, P.M., Kemp, K., Anderson, D.E., McCermant, S.K., and Bauman, D.D. (1987) Bio-availability of oestradiol as a marker for breast cancer risk assessment, Cancer Research 47, 5224–5229.

    PubMed  CAS  Google Scholar 

  • Katzenellenbogen, J.A. (1995) The structural pervasiveness of oestrogenic activity, Environ. Health Perspect. 103 Suppl. 7?? 99–101.

    Google Scholar 

  • Kang, K.S., Wilson, M.R., Hayashi, T., Chang, C.C., and Trosko, J.E. (1996) Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures, Environ. Health Perspect. 104, 192–200.

    Google Scholar 

  • Kandi, H., Seymour, L., and Bezwoda, W.R. (1994) Soluble-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer, Brit. Jl. Cancer 70, 739–742.

    Article  Google Scholar 

  • Kettles, M.A., Browning, S.R., Scott Prince, T., and Horstman, S.W. (1997) Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky Counties, Environ. Health Perspect. 105, 1222–1227.

    Article  PubMed  CAS  Google Scholar 

  • Klotz, D.M., Beekman, B.S., Hill, S.M., McLachlan, J.A., Walters, M.R., and Arnold, S.F. (1996) Identification of environmental chemicals with oestrogenic activity using a combination of in vitro assays, Environ. Health Perspect. 104, 1084–1089.

    Article  PubMed  CAS  Google Scholar 

  • Krieger, N., Wolff, M.S., Hiatt, R.A., Rivera, M., Vogelman, J., and Orentreich, N. (1994) Breast cancer and serum organochlorines: a prospective study among white, black and Asian women, Jl. Natl. Cancer. Inst. 86, 589–599.

    Article  CAS  Google Scholar 

  • Lacassagne, A. (1948) Les hormones et leurs relations avec le cancer, Schweiz. Med. Wochenschr. 78, 705–708.

    PubMed  CAS  Google Scholar 

  • Langley, M.S., Hammond, G.L., and Bardsley, A. (1985) Serum steroid binding protein and the bio-availability of oestradiol in relation to breast diseases, J. Natl. Cancer Inst. 75, 823–829.

    PubMed  CAS  Google Scholar 

  • Lupulescu, A. (1995) Oestrogen use and cancer incidence: a review, Cancer Investigation 13 (3), 287–295.

    Google Scholar 

  • Miyaizi, S., Ichikawa, T., and Nombara, T. (1991) Structure of the adduct of 16 ahydroxyoestrone with a primary amine: evidence for the Heyns rearrangement of steroidal D-ring a-hydroxyimines, Steroids 56, 361–366.

    Article  Google Scholar 

  • Moore, J.W., Clark, G.M., and Bulbrook, R.D. (1982) Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls, Int. J. Cancer 29, 17–21.

    Article  PubMed  CAS  Google Scholar 

  • Moore, J.W., Clark, G.M.G., and Hoare, S.A. (1986) Binding of oestradiol to blood proteins and etiology of breast cancer, Int. J. Cancer 38, 625–630.

    Article  PubMed  CAS  Google Scholar 

  • MRC Institute for Environmental and Health (1996) Report for the Weybridge Workshop on Endocrine Disrupters,pp. 12–14.

    Google Scholar 

  • Mussalo-Rauhamaa, H.?? Häsänen, E., Pyysalo, H., Antervo, K., Kauppila, R., and Pantzar, P. (1990) Occurrence of ß-Hexachlorocyclohexane in breast cancer patients, Cancer 66?? 2124–2128.

    Google Scholar 

  • Nagel, S.C., vom Saal, F.S., Thayer, K.A., Dhar, M.G., Boeckler, M., and Welshons, W.V. (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol-A and octylphenol, Environ. Health Perspect. 105, 70–76.

    Article  PubMed  CAS  Google Scholar 

  • Okey, A.B., Riddick, D.S., and Harper, P.A. (1994) The Ah-receptor: mediator of the toxicity of 2,3,7,8-Tetra-chlorodibenzo-p-dioxin (TCDD) and related compounds, Toxicology Letters 70, 1–22.

    Article  PubMed  CAS  Google Scholar 

  • Ota, D.M., Jones, L.A., Jackson, G.L., Jackson, P.M., Kemp, K., and Bauman, D. (1986) Obesity, non protein bound oestradiol levels, and distribution of oestradiol in the sera of breast cancer patients, Cancer 57, 558–562.

    Article  PubMed  CAS  Google Scholar 

  • Pappas, T.C., Gametchu, B., Yannariello-Brown, J., Collins, T.J., and Watson, C.S. (1994) Membrane oestrogen receptors in GH3/B6 cells are associated with rapid oestrogen-induced release of prolactin, Endocrine 2, 813–822.

    Google Scholar 

  • Safe, S. (1995) Environmental and dietary oestrogens and human health–is there a problem? Environ. Health Perspect. 103, 346–351.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J., Hugh, M.M., Bradlow, H.L., and Fishman, J. (1984) Anti-oestrogen action of 2-hydroxyoestrone on MCF-7 human breast cancer cells, fl. Biol. Chem. 259, 4840–4845.

    CAS  Google Scholar 

  • Siiteri, P.K., Hammond, G.L., and Nisker, J.A. (1981) Increased availability of serum oestrogens in breast cancer: a new hypothesis, Banbury Rep. 8, 87.

    CAS  Google Scholar 

  • Soto, A.M., Lin, T.H., Justicia, H., Silvia, R.M., and Sonnenschein, C. (1992) An `in culture’ bioassay to assess the oestrogenicity of xenobiotics, in T. Colborn and C. Clement (eds), Chemically Induced Alterations in Sexual and Functional Development: the Wildlife/Human Connection, Princeton Scientific Publishing, Princeton, N.J., 295–309.

    Google Scholar 

  • Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea, N., and Olea Serrano, F. (1995) The E-SCREEN assay as a tool to identify oestrogens: an update on oestrogenic environmental pollutants, Environ. Health Perspect. 103 Suppl. 7?? 113122.

    Google Scholar 

  • Stancel, G.M., Boettger-Tong, H.L., Chiappetta, C., Hyder, S.M., Kirkland, J.L.?? Murthy, L.?? and Loose-Mitchel, D.S. (1995) Toxicity of endogenous and environmental oestrogens: what is the role of elemental interactions? Environ. Health Perspect. 103 Suppl. 7?? 29–33.

    Google Scholar 

  • Suto, A., Bradlow, H.L., Wong, G.Y., Osborne, M.P., and Telang, NT. (1993) Experimental down regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells, Breast Cancer Res. Treat. 27, 193–202.

    Article  PubMed  CAS  Google Scholar 

  • Telang, N.T., Suto, A., Wong, N.Y., Bradlow, H.L., and Osborne, M.P. (1992) Induction by the oestrogen metabolite 16 a-hydroxyoestrone, of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells, J. Natl Cancer Inst. 84, 634–638.

    Article  PubMed  CAS  Google Scholar 

  • Traganos, F., Ardelt, B., Halko, N., Bruno, S., and Darzynkiewicz, Z. (1992) Effect of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 Cells, Cancer Research 52, 6200–6208.

    PubMed  CAS  Google Scholar 

  • Travis, C.C., and Belefant, H. (1992) Promotion as a factor in carcinogenesis, Toxicology Letters 60, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Trosko, J.E., Jone, C., and Chang, C.C. (1983) The role of tumour promoters on phenotypic alterations affecting intercellular communication and tumourigenesis, Ann. NYAcad. Sci. 407, 316–327.

    Article  PubMed  CAS  Google Scholar 

  • Unger, M., Kiaer, H., Blichert-Toft, M., Olsen, J., and Clausen, J. (1984) Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery, Environ. Res. 34, 24–28.

    Article  PubMed  CAS  Google Scholar 

  • vom Saal, F.S. (1995) Environmental oestrogenic chemicals: their impact on embryonic development, Human and Ecological Risk Assessment 1 (2), 3–15.

    Google Scholar 

  • vom Saal, F.S. (1997) Presentation at the conference of endocrine disrupting chemicals, the Global International 12`h General Assembly, European Parliament, Brussels, 7 May 1997.

    Google Scholar 

  • Wasserman, M., Nogueira, D.P., Tomatis, L., Mirra, A.Q.P., Shibata, H.?? Arie, G., Cucos, S., and Wasserman, D. (1976) Organochlorine Compounds in neoplastic and adjacent apparently normal breast tissue, Bull. Environ. Contam. Toxicol. 15, 478484.

    Google Scholar 

  • Watson, C.S., Pappas, T.C., and Gametchu, B. (1995) The other oestrogen receptor in the plasma membrane: implications of the actions of environmental oestrogens, Environ. Health Perspect. 103 Suppl. 7?? 41–52.

    Google Scholar 

  • Welsch, C.W. (1978) Prolactin and the development and progression of early neaplastic mammary gland lesions, Cancer Research 38, 4054–4058.

    PubMed  CAS  Google Scholar 

  • Welshons, W.V., Nagel, S.C., Thayer, K.A., Judy, B.M., and vom Saal, F.S. (1999) Low-dose bioactivity of xenoestrogens in animals: fetal-exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice, Toxicology and Industrial Health 15, 12–25.

    Article  PubMed  CAS  Google Scholar 

  • Wolff, MS., and Toniolo, P.G. (1995) Environmental organochlorine exposure as a potential etiologic factor in breast cancer, Environ. Health Perspect. 103 Suppl. 7?? 141–145.

    Google Scholar 

  • Wolff, M.S., and Weston, A. (1997) Breast cancer risk and environmental exposures, Environ. Health Perspect. 105 Suppl. 4?? 891–896.

    Google Scholar 

  • Wolff, M.S., Toniolo, P.G., Lee, E.W., Rivera, M., and Dubin, N. (1993) Blood levels of organochlorine residues and risk of breast cancer, B. Natl. Cancer Inst. 85, 648–652.

    Article  CAS  Google Scholar 

  • Yanai, R., and Nagazawa, H. (1976) Effects of pituitary graft and 2-bromo-a-ergocryptine on mammary DNA synthesis in mice, in relation to mammary tumourigenesis, JNCI 56, 1055–1056.

    PubMed  CAS  Google Scholar 

  • Yu, S.C., and Fishman, J. (1985) Interaction of histones with oestrogens. Covalent adduct formation with 16 a-hydroxyoestrone, Biochemistry 24, 8017–8021.

    Article  PubMed  CAS  Google Scholar 

  • Zaridze, D.?? Kushlinskii, N., Moore, J.W., Lifanova, Y., Bassalyk,,L., and Wang, D.Y. (1992) Endogenous plasma sex-hormones in pre-and postmenopausal women with breast cancer: results from a case-control study in Moscow, Europ. J. Cancer Prey. 1?? 225–230.

    Google Scholar 

  • Zhou-Li, F., Albaladejo, V., Joly-Pharabozz, M.O., Nicolas, B., and Andre, J. (1992) Anti-oestrogens prevent the stimulatory effects of L-tri-iodothyronine on cell proliferation, Endocrinology 130, 1145–1152.

    Article  PubMed  CAS  Google Scholar 

  • Zhu, B.T., Bui, Q.D., Weisz, H., and Liehr, J.G. (1994) Conversion of oestrone to 2- and 4-hydroxyoestrone by hamster kidney and liver microsomes: implications of the mechanism of oestrogen-induced carcinogenesis, Endocrinology 16 (35)?? 1772–1779.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Pluygers, E., Sadowska, A. (2001). Mechanisms Underlying Endocrine Disruption and Breast Cancer. In: Nicolopoulou-Stamati, P., Hens, L., Howard, C.V. (eds) Endocrine Disrupters. Environmental Science and Technology Library, vol 18. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9769-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-9769-2_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5729-7

  • Online ISBN: 978-94-015-9769-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics